Participants 121 189 8
patients <65 years with poor prognosis histologically aggressive NHL
Participants 192 224 8
This trial involved 457 patients
Participants 286 504 8
autologous transplantation in patients with poor prognosis histologically aggressive non-Hodgkin lymphoma (NHL) showing a response to initial CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy
